Laurence N. Charney Sells 17,500 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) Stock

TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) Director Laurence N. Charney sold 17,500 shares of the company’s stock in a transaction that occurred on Friday, January 5th. The shares were sold at an average price of $19.03, for a total value of $333,025.00. Following the completion of the sale, the director now owns 237,229 […]

Related Keywords

Laurencen Charney , ,Nasdaq ,Tg Therapeutics Company Profile ,Jefferies Financial Group ,Geode Capital Management ,Securities Exchange Commission ,Tg Therapeutics Inc ,Vanguard Group Inc ,Blackrock Inc ,Darwin Global Management Ltd ,Jpmorgan Chase Co ,Get Free Report ,Director Laurence ,Exchange Commission ,Street Corp ,Global Management ,Capital Management ,Tg Therapeutics ,Nasdaq Tgtx ,Tgtx ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,